JP2022047090A - Medicament packaging making apparatus - Google Patents

Abstract

To provide a medicament packaging making apparatus that can promote efficiency of work for collecting medicament.SOLUTION: A medicament packaging making apparatus can make medicament be contained in the medicament packaging of a prescribed size, and can perform the packing operation for making the medicament packaging of the prescribed size by only the fixed number. In the apparatus, the collection operation for collecting the medicament used in the packing operation is made possible. In the collection operation, the collected medicament are contained in the medicament packaging 50 with the size different from the prescribed size, and/or are contained in the medicament packaging of the number being less than the fixed number.SELECTED DRAWING: Figure 7

Description

The present invention relates to a drug packaging manufacturing apparatus that manufactures a drug package in which drugs are individually packaged.

In recent years, drug dispensing devices such as powder packing machines and tablet packing machines have been introduced in hospitals and pharmacies. The drug dispensing device is a device that individually packages and dispenses drugs such as tablets and powders one by one, and for example, there is one disclosed in Patent Document 1. The drug dispensing device (drug dispensing device) disclosed in Patent Document 1 is a device capable of a packaging operation in which powdered medicine is packaged for each dose based on the information regarding the prescription.

Specifically, when executing the packaging operation, an operation of supplying a predetermined amount of powder from the drug container to the distribution dish, an operation of charging the powder into the drug packaging device from the distribution dish for each dose, and a drug packaging device. Perform the action of packaging powder in. As a result, a drug package containing a single dose of the drug is produced and discharged to the outside.

Further, as such a drug packaging device, there is a heat sealing device disclosed in Patent Document 2. As shown in FIG. 10, this heat seal device has a heater stand 900 and a heater cradle 901, both of which are members extending in a substantially T shape. Then, when forming the package 910 containing the drug, the heater stand 900 and the heater cradle 901 arranged at opposite positions across the packaging sheet are brought close to each other. At this time, the heat-welded surface of the packaging sheet sandwiched between the heater base 900 and the heater pedestal 901 is heat-sealed.

Specifically, as shown in FIG. 10B, one package 910 is closed on three sides by two partition seal walls 920 and one block seal wall 921. The partition seal wall 920 and the block seal wall 921 are portions formed by heat-sealing the packaging sheets, and are portions in which parts of the overlapping packaging sheets are heat-welded to each other. The partition seal wall 920 is a portion extending in the width direction of the package 910, and is formed one by one at positions separated in a direction orthogonal to the same width direction. The block seal wall 921 is a portion extending in a direction orthogonal to the width direction of the package 910, and extends between the two partition seal walls 920.

In the heat seal device of Patent Document 2, one of the partition seal wall 920 and a part of the block seal wall 921 are formed by the first pinching operation. Then, by the second pressing operation, the remaining portion of the closing seal wall 921 and the other partition sealing wall 920 are formed. This forms a package 910 of a specified size.
Here, the heat-sealing device of Patent Document 2 cannot widen the distance between the two partition seal walls 920 to a predetermined distance or more, and cannot form a package 910 having a size larger than a predetermined size. .. More specifically, if the distance between the two partition seal walls 920 is widened beyond a certain level, a part of the block seal wall 921 formed together with one partition seal wall 920 and a block block formed together with the other partition seal wall 920. A part of the seal wall 921 is formed at a position away from the seal wall 921. In this case, the formed package 910 does not form a body as a package 910 because the closed seal wall 921 is intermittent and the contained medicine leaks from the interrupted portion of the closed seal wall 921. That is, the heat-sealing device of Patent Document 2 cannot widen the distance between the two partition seal walls 920 beyond a predetermined distance, and manufactures a package 910 having a closed seal wall 921 having a length exceeding a predetermined length. Can not. Furthermore, the heat-sealing device of Patent Document 2 does not assume that the size of the package 910 is changed in the first place.

Japanese Unexamined Patent Publication No. 2019-198639 Japanese Unexamined Patent Publication No. 2005-335810

Here, the prescription may be changed after the packaging operation is started. Before the packaging operation is started, the execution of the packaging operation may be stopped, but if the packaging operation is started and the powder has already been supplied to the distribution dish, the packaging operation is immediately stopped. However, the powder remains on the distribution plate.

Therefore, in the conventional drug dispensing device, even if the prescription is changed after the packaging operation is started, the packaging operation is executed as it is. Then, when the drug package prepared based on the prescription before the change is dispensed, the user (pharmacist, etc.) of the drug dispenser who received the drug package breaks it and does not need to provide the drug to the patient. It was being collected.

Here, since one drug package contains one dose of powdered drug, one patient can receive the same drug for a plurality of times (for example, after breakfast, after lunch, before dinner, etc. on a predetermined day). When prescribed, multiple drug packages containing the same drug are produced. For example, if a drug to be taken 3 times a day (eg, morning, noon, night) is prescribed for 3 weeks (21 days), 63 drug packages will be produced. When a patient is prescribed some drug, usually, a certain period of time (for example, one week) is prescribed in this way, and the number of drug packages to be produced is often large.

When a large number of drug packages are produced based on the prescription before the change, it takes time for the drug packages containing the drugs to be collected to be discharged, and the drugs are collected one by one in order to recover the drugs. The work of breaking the packaging was troublesome. In addition, since a large amount of raw material (packaging paper) is consumed to produce a drug package containing the drug to be recovered, there is room for improvement in terms of reducing waste of the raw material.

Therefore, it is an object of the present invention to provide a drug packaging manufacturing apparatus capable of improving the efficiency of the work of collecting a drug.

One aspect of the present invention for solving the above-mentioned problems is a drug packaging manufacturing apparatus for manufacturing a drug package containing a drug, wherein the drug is encapsulated in the drug package having a specified size, and the above-mentioned specification is made. It is possible to perform a packaging operation in which a specified number of the drug packages of the size are dispensed, and a collection operation in which the drug scheduled to be used in the packaging operation is collected. In the collection operation, the drug is collected. A drug packaging manufacturing apparatus for encapsulating a drug in the drug package having a size different from the specified size and / or encapsulating the drug in a number smaller than the specified number of the drug packages.

In this aspect, by encapsulating the drug to be collected in a drug package having a size different from the specified (normal) size, it is easy to distinguish between the drug package containing the recovered drug and the normal drug package. It becomes possible to do. That is, it is possible to easily identify the drug package containing the drug to be recovered. Therefore, it is possible to suppress the occurrence of human error such as accidentally tearing the drug packaging to be provided to the patient. In addition, when the drug to be collected is contained in a drug package larger than the normal drug package, it is possible to store a large number of drugs (drugs to be collected) in one drug package, and the drug produced to collect the drug. The number of packages can be reduced. As a result, it is possible to reduce the number of drug packages to be torn for recovery, and it is possible to reduce the labor of collecting the drug. When the amount (or number) of the drug to be recovered is small, the drug package to be recovered is housed in a drug package smaller than the normal drug package, so that the amount of the drug package produced for the recovery of the drug is smaller. It can be manufactured with, and the waste of raw materials for drug packaging can be reduced.

By the way, it is preferable to store a certain amount of the drug in the drug package, which is smaller than the maximum amount that can be actually stored. In other words, if the drug is contained in the drug package in pieces, the drug package may be unintentionally torn and damaged before the operator tears it, so the drug is included with a margin. It is preferable to let it. However, if the drug is encapsulated in the drug package with a margin, it is necessary to increase the size of the drug package, so that more raw materials for producing the drug package are required. That is, when producing a drug package, a raw material for forming a portion for providing a margin (hereinafter, also referred to as a margin) is further required.
From the above, when the number of drug packages to be prepared for drug recovery is large, if the drug is included in each drug package with a margin, a margin is formed for each drug package. More raw materials are needed to do this. As a result, the total amount of raw materials for drug packaging required to contain the drug with a margin becomes very large.
On the other hand, in this aspect, the drug to be recovered is included in a smaller number of drug packages than the specified number, and the number of drug packages to be prepared for recovery is reduced, so that the drug to be recovered can be packed in the drug package with a margin. When included, the total amount of raw materials required to form a margin can be reduced. That is, it is possible to reduce the number of drug packages to be broken by the worker, and when the drug is included with a margin, the total amount of raw materials for the drug packaging required for that purpose can be reduced.
As described above, according to this aspect, the labor of collecting the drug, the waste of the raw material of the drug packaging required for the recovery, and the occurrence of human error that may occur during the work are suppressed. It becomes possible to improve the efficiency of work.

In the above-mentioned aspect, in the recovery operation, it is preferable to enclose the drug to be recovered in one drug package larger than the specified size.

According to this preferred aspect, when recovering a drug, one drug package may be broken, and the work for recovery is easy. In addition, the drug packaging containing the drug to be collected is large and conspicuous, so that the difference from the normal drug packaging is easier to understand. Further, when the drug to be recovered is included in the drug packaging with a margin, only one margin is formed, and the raw material for the drug packaging required for including the drug with a margin can be reduced.

In the above aspect, the drug package has a storage space in which the drug is stored and a seal portion adjacent to the storage space, and the storage space is closed by the seal portion. In the recovery operation, recovery is performed. It is preferable to change the length of the seal portion of the drug package containing the drug to be recovered, depending on the type of the drug to be collected.

According to this preferred aspect, the drug packaging produced for recovery can be of an appropriate length (size) according to the type of drug to be recovered.

In the above aspect, the drug package has a storage space in which the drug is stored and a seal portion adjacent to the storage space, and the storage space is closed by the seal portion, and the seal portion is divided. In the collection operation, the partition paper is included according to the type of the drug to be collected in the operation of forming the delivery forming portion. It is preferable to change the number of times of sending out.

According to this favorable aspect, when preparing a drug package for recovery, it is difficult to supply a large amount at one time to the drug package (separate packaging bag) in the process of preparation (for example, in the drug package). Even if it is a drug that is difficult to flow, it can be packaged appropriately.
That is, in this aspect, a part of the horizontal seal portion is formed with the first delivery, and the subsequent portion is formed with the second delivery. Can be formed separately.
From this, for example, one of the other drugs that forms a part of the containment space and introduces a part of the drug to be contained (recovered) into the formed part, and then forms a continuous part of the containment space and contains the drug. It becomes possible to execute the operation of introducing the part. Then, by repeating a series of operations including an operation of forming a part of the storage space and an operation of introducing a part of the drug to be contained, a drug package for collecting the drug can be formed.

In the above aspect, it is preferable that the packaging operation is an operation executed based on the packaging setting information, and the collection operation is an operation executed based on the collection setting information (claim 5). ..

The preferred aspect described above is that the drug package has a storage space in which the drug is stored and a seal portion adjacent to the storage space, and the storage space is closed by the seal portion. The partition portion includes a delivery forming portion, which is a portion formed by sealing while feeding the packaging paper, and a partition portion, and the partition portion extends in a direction intersecting the extension direction of the delivery formation portion. The packaging setting information is information for determining the number of the drug packages produced by the packaging operation, and for determining the length of the delivery forming portion of the drug packaging produced by the packaging operation. The collection setting information includes one or more information selected from information, information for determining the delivery speed of the packaging paper when producing the drug package in the packaging operation, and the collection setting information is described in the collection operation. Information for deciding whether or not to simultaneously introduce the drug and send out the packaging paper when manufacturing the drug package, and to determine the interval between the partitions of the drug package manufactured by the recovery operation. It is more preferable to include one or more information selected from the information, the information for determining the delivery speed of the packaging paper when the drug package is produced in the recovery operation (claim 6).

According to the present invention, it is possible to provide a drug packaging manufacturing apparatus capable of improving the efficiency of the work of collecting a drug.

It is a perspective view which shows the drug packaging manufacturing apparatus which concerns on embodiment of this invention. (A) is an explanatory diagram schematically showing a main part of the drug packaging device of FIG. 1, and (b) is an explanatory diagram showing a drug packaging band manufactured by the drug packaging device. It is explanatory drawing which shows the main part of the sealing device of FIG. It is explanatory drawing which shows the heating body part of FIG. 3, (a) shows the state which the 2nd rotation shaft part and the 2nd heating member are rotatably attached to the 1st rotation shaft part, (b) is A state in which the second rotating shaft portion and the second heating member are removed from the first rotating shaft portion is shown. (A) is an explanatory diagram schematically showing how the two first heating members take a heating posture, and (b) schematically shows how the two first heating members take a non-heating posture. It is explanatory drawing. It is explanatory drawing which shows the state of manufacturing the drug packaging by the drug packaging apparatus of FIG. 3, and is manufacturing in the order of (a) to (c). (A) is an explanatory diagram showing a state in which a recovery drug package is formed by the drug packaging device of FIG. 1, and (b) is an explanatory diagram showing a recovery drug package produced by the drug packaging device. .. It is explanatory drawing which shows typically the drug packaging apparatus different from the said embodiment. It is explanatory drawing which shows typically the drug packaging manufacturing apparatus different from the said embodiment. It is explanatory drawing which shows the state of forming the medicine package by the conventional heat-sealing device schematically, and the medicine package is formed in the order of (a), (b).

Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings, but the present invention is not limited to these examples. Further, in the following description, the “powder” includes a drug powdered by grinding a solid drug such as a tablet.

The drug dispensing device 1 (drug packaging manufacturing device) of the present embodiment is a powder packaging machine, and as shown in FIG. 1, a drug storage area 2, a drug dividing area 3, and a drug packaging area 4 are inside the housing. Has. It also has a display device 5 attached to the outside of the housing.
The drug dispensing device 1 has a control unit (not shown). The control unit includes a calculation unit such as a CPU, a storage unit (storage means) having a main storage device such as a ROM and RAM, and a communication unit such as an I / О port. For this reason, the drug dispensing device 1 can transmit and receive various signals and various information to and from external devices (upper control device (not shown, dispensing device such as weighing device, external PC, etc.)). In addition, various information can be stored.

The drug storage area 2 is provided with a container storage unit 11 for holding a plurality of drug containers 10. The container storage unit 11 of the present embodiment is a drum member, which is a member for holding the drug container 10 in an upright posture. Further, each of the plurality of drug containers 10 contains a drug (powder). That is, a plurality of types of drugs are housed in different drug containers 10.
For convenience of drawing, only some of the drug containers 10 are designated with reference numerals, and the codes for other drug containers 10 are omitted. Similarly, in the following description, when a plurality of the same or the same main parts are depicted in each drawing, some reference numerals may be omitted as necessary.

Here, a container moving means 13 is provided inside the housing of the drug dispensing device 1. The container moving means 13 is a robot having an arm portion, a hand portion, and an elevating mechanism for raising and lowering the arm portion, and can hold and move (carry) the drug container 10.

The drug division region 3 is provided with two distribution dishes 20, a container mounting device 21, a scraping device 22, and a drug inlet 23. Specifically, a plurality of (three) container mounting devices 21 and one scraping device 22 are associated with one distribution dish 20.

The distribution plate 20 is a member that has a groove portion that is continuous in an annular shape and can be rotated by a rotation mechanism including a motor.
The container mounting device 21 is a member that constitutes a drug feeder together with the drug container 10. That is, a shaking table equipped with a container holding means such as a magnet for holding the placed medicine container 10 and a vibration means for vibrating the placed medicine container 10 and vibration. It has a weight measuring means capable of measuring the weight of the drug container 10 placed on a table.
The scraping device 22 is composed of an arm portion and a scraping mechanism provided at the tip of the arm portion. The scraping mechanism has a disk-shaped scraping plate that is rotated by power and a scraping plate arranged on one main surface side of the scraping plate.
The drug inlet 23 is provided between the two distribution dishes 20 and is a portion for supplying the drug from the drug dividing region 3 to the drug packaging region 4 (drug packaging device 30).

The drug packaging area 4 is provided with a drug packaging device 30.

As shown in FIG. 2, the medicine packaging device 30 includes a medicine wrapping paper holding means for holding a roll-shaped packing paper 31 (medicine wrapping paper), a sheet feeding means 32 for feeding out and feeding the roll-shaped packing paper 31, and a hopper. It has a member 33, a bag forming device 34, a cutting device 35, and a printing means 36.

The hopper member 33 is located on the downstream side of the drug charging port 23 (see FIG. 1), and is a member into which the pre-packaging drug charged into the drug charging port 23 is introduced.

The bag forming device 34 folds the packing paper 31 sent by the sheet feeding means 32 in half, and crimps, fuses, or the like to the folded paper 31 in half so that the packing paper 31 is brought into close contact with the bag shape. It is a device that can be used. The bag forming device 34 of the present embodiment has a triangular plate 34a and a sealing device 34b. Then, after the drug is charged from the hopper member 33 between the inner side surfaces of the folded paper 31, the drug package 40 is manufactured by closing (sealing) the periphery of the portion into which the drug is charged. (Details will be described later).

The triangular plate 34a is a member for folding the sent packing paper 31 in half at a substantially central portion in the width direction.
The sealing device 34b of the present embodiment is a heat sealing device and has a pair of heating body portions 60 as shown in FIG. Each heating body unit 60 includes a first heating body 61 and a second heating body 62, and each of the first heating body 61 and the second heating body 62 can rotate independently.
Specifically, as shown in FIG. 4, the first heating body 61 and the first rotating shaft portion 63 are integrally formed, and the second heating body 62 is integrally formed with the second rotating shaft portion 64. ing. Then, the second rotating shaft portion 64 and the second heating body 62 are in a state of being externally fitted to a part of the first rotating shaft portion 63.

Further, a heater for heating (not shown) is provided inside the first heating body 61. Then, the heater is operated by receiving electric power from the outside, and the first rotating shaft portion 63 is heated by the heater, so that the temperature of the first heating body 61 and the second heating body 62 rises.

Further, as shown in FIG. 3, the sealing device 34b has a first rotation mechanism 67 for rotating the first rotation shaft portion 63 and a second rotation mechanism 68 for rotating the second rotation shaft portion 64.
The first rotation mechanism 67 is composed of a motor 70, a spur gear mechanism 71 attached to the first rotation shaft portion 63, and a power transmission mechanism for transmitting power between them.
The spur gear mechanism 71 has a gear portion integrally attached to one first rotating shaft portion 63 and a gear portion integrally attached to the other first rotating shaft portion 63, and these are in mesh with each other. It has become. Therefore, when the motor 70 operates and receives power from the power transmission mechanism to rotate one of the gear portions, the two first rotation shaft portions 63 rotate in opposite directions to each other. As a result, the two first heating bodies 61 also rotate in opposite directions to each other.

Here, as shown in FIG. 5 and the like, each first heated body 61 has a heated surface 61a and a non-heated surface 61b on a part of the side surface. The heated surface 61a and the non-heated surface 61b are surfaces that are continuous in the circumferential direction around the rotation axis. The two first heating bodies 61 rotate in opposite directions so that the heating surfaces 61a face each other in a heating posture (see FIG. 5A) and the non-heating surfaces 61b face each other in a non-heating posture. It is possible to change the posture with (see FIG. 5 (b)).
The heated surface 61a is a curved surface that comes into contact with the packing paper 31, and the non-heated surface 61b is a flat surface that does not come into contact with the packing paper 31. Further, the heating surface 61a is provided with a perforation blade 75, so that perforations can be made at the same time as the heating seal.
The first rotation mechanism 67 may be provided with a position detection sensor that detects the mutual position (rotational position) of the two first heating bodies 61.

As shown in FIG. 3, the second rotation mechanism 68 includes a motor 80, a spur gear mechanism 81 attached to the second rotation shaft portion 64, and a power transmission mechanism for transmitting power between them. .. The spur gear mechanism 81 has a gear portion integrally attached to one second rotating shaft portion 64 and a gear portion integrally attached to the other second rotating shaft portion 64, and these are meshed with each other. It is in a state of being. Therefore, due to the operation of the motor 80, the two second rotation shaft portions 64 rotate in opposite directions to each other.
The second heating body 62 is a surface that comes into contact with the packing paper 31, and has a brim-shaped heating surface 62a that is continuous in an annular shape (see FIG. 4 and the like).

That is, the first heating body 61 and the second heating body 62 belonging to one heating body unit 60 rotate about the same rotation center line α1 as shown in FIG. 4A and the like. More specifically, the virtual line connecting the rotation centers of each part of the first heating body 61 and the virtual line connecting the rotation centers of each part of the second heating body 62 are located on the same straight line. The rotation center line α1 is a virtual line located on this straight line. That is, the rotation center of each part of the first heating body 61 and the rotation center of each part of the second heating body 62 are at the same position in the transport direction (delivery direction) of the packing paper 31 (FIG. 2, etc.). reference). The first heating body 61 and the second heating body 62 are arranged side by side in the extending direction of the rotation center line α1 (vertical direction in FIG. 4). Therefore, these heating surfaces 61a and 62a are also in a state of being adjacent to each other in the same direction.
Further, as described above, the first heating body 61 and the second heating body 62 rotate by receiving power supply from different power supply sources (motors 70, 80). The first rotation mechanism 67 and the second rotation mechanism 68 are controlled by the control unit of the drug dispensing device 1, and the first heating body 61 and the second heating body 61 and the second heating body 61 have an appropriate rotation angle (rotation amount) in each operation. It is possible to rotate the body 62 individually.

As shown in FIG. 2, the cutting device 35 includes a cutter (cutting blade) capable of cutting the packing paper 31, and cuts the packing paper 31 in the shape of a bag by containing a drug inside. It is a device for forming the drug packaging 40 and the drug packaging band 41 (details will be described later).

The printing means 36 is a device for printing predetermined information on the packing paper 31 sent by the sheet feeding means 32. Specifically, printing is performed on the packing paper 31 before the bag shape, and the printing is performed at a position upstream of the bag forming device 34 in the transport direction of the packing paper 31.

The display device 5 is a device capable of displaying various information, and as shown in FIG. 1, specifically, a touch panel in which a device for displaying information such as a liquid crystal panel and a position input device such as a touch pad are combined. Is. That is, the display device 5 is also a part (input receiving unit) that receives an operation (input) by the user, and by inputting to the display device 5, each device belonging to the drug dispensing device 1 and the drug dispensing device 1 , Various operations can be requested from each device.

Subsequently, the basic packaging operation that can be performed by the drug dispensing device 1 will be described.

The packaging operation is an operation of packaging a drug (powder) one package at a time (for example, one dose) based on the information on the prescription acquired by the drug dispensing device 1 (hereinafter, also referred to as prescription data). The prescription data may be received from an external device or may be input from the display device 5. The prescription data includes information on the drug prescribed to the patient.

Specifically, first, the drug container 10 stored in the container storage unit 11 is moved to the container mounting device 21 by the container moving means 13 and placed on the container mounting device 21 to form a drug feeder to form a drug. The container 10 is vibrated. As a result, the drug contained in the drug container 10 is dropped onto the distribution dish 20 and the drug is supplied to the distribution dish 20. At this time, the distribution plate 20 is rotated prior to the supply of the drug to the distribution plate 20. That is, the drug is supplied to the rotating distribution dish 20.

Here, when the drug container 10 is vibrated, a desired amount of drug is supplied (dropped) by measuring the weight of the drug container 10 placed on the container mounting device 21. At this time, the weight of the drug container 10 is constantly monitored, and the measurement is continued even while the drug is being supplied. That is, the weight of the drug container 10 before the start of vibration (or immediately after the start of vibration) is stored as the original weight G. Then, even during the supply of the drug (during the vibration of the drug container 10), the current weight (current weight g) of the drug container 10 is continuously monitored. Further, during the supply of the drug, the operation of comparing the original weight G and the current weight g and calculating the supply amount H (H = Gg) of the drug is constantly executed. Then, when the supply amount H of the drug reaches a desired amount (weight), the vibration of the drug container 10 is stopped, and the supply of the drug from the drug container 10 is completed. The supply amount H of the drug is, of course, also the discharge amount (drop amount) of the drug from the drug container 10.

When the operation of supplying the medicine to the distribution plate 20 is completed, the rotation of the distribution plate 20 is stopped thereafter. Then, by lowering the tip end side of the arm portion of the scraping device 22, the scraping plate on the tip end side of the arm portion is put in the groove of the distribution plate 20. Then, in the same state, the distribution plate 20 is rotated by an angle corresponding to the number of distributions, and a scraping operation is executed. As a result, the drug is scraped around the scraping plate. The "distributed number" here is the number (specified number) of the drug packages 40 to be produced by the packaging operation. For example, it is "3" when producing 3 (3 packages) drug packages 40, and "10" when producing 10 (10 packages) drug packages 40.

Subsequently, the scraping plate is rotated to perform a scraping operation in which the scraped medicine is scooped up by the scraping plate. As a result, the drug is discharged from the distribution dish 20 and charged into the drug inlet 23. In the present embodiment, the medicines on the distribution plate 20 are charged into the medicine inlet 23 one by one by the scraping operation and the scraping operation. In principle, one packet of drug is charged into the drug inlet 23 by one scraping operation and one scraping operation, but the present invention is not limited to this, and when one packet of drug is charged, scratching is performed. The pulling operation and the scraping operation may be executed a plurality of times.

The drug charged into the drug charging port 23 is supplied to the drug packaging device 30, passes through the inside of the hopper member 33 (see FIG. 2), and then is packaged in the drug packaging device 30.
Specifically, in the drug packaging device 30, as shown in FIG. 2, the drug introduced into the hopper member 33 is packaged one by one to form the drug package 40. Further, when a plurality of drug packages 40 are produced, the drug packaging band 41 (which is a continuum of the drug packages 40) in which the plurality of drug packages 40 are connected in a band shape is produced. At this time, the printing means 36 applies predetermined printing to the drug packaging 40. Specifically, by printing predetermined information on the packing paper 31 prior to the production of the drug package 40, the drug package 40 to be produced is printed.

When the drug packaging band 41 is manufactured, an accessory portion may be formed on the drug packaging band 41. The accessory portion referred to here is, for example, a header portion provided at the beginning, and the header portion is formed by an empty sachet (empty package) containing no drug. Then, the above-mentioned printing may be applied to this accessory portion. That is, the printing means 36 is a device capable of performing predetermined printing on the drug packaging 40 formed by the drug packaging device 30 and its accessory portions.

The drug package 40 includes a drug to be packaged and a packaging portion (bag portion) that constitutes an outer portion and seals and packages the packaged object (drug). As shown in FIG. 2, the outer portion of the drug package 40 is roughly divided into a storage area 40a and a non-containment area 40b. The accommodating area 40a is an area in which an accommodating space 45, which is a space for accommodating a drug, is formed. The non-containing region 40b is a portion where the drug is not accommodated and is a region where a sealing portion is formed.

The sealing portion is a portion formed on the edge portion of the drug package 40, and is formed by sealing the periphery of the accommodating region 40a by heat fusion or the like. Specifically, this seal portion is a portion where the overlapping packing papers 31 are fused (adhered to a state in which they are not separated) by folding in half, and the first seal portion 47 (partition portion) and the second seal are formed. It is composed of a unit 48 (formation unit at the time of delivery). In this embodiment, one drug package 40 has two first seal portions 47 and one second seal portion 48.

The first seal portion 47 is a portion extending in a band shape in the width direction of the drug package 40, and is a vertical seal portion extending in the vertical direction when the drug package 40 is viewed from the front. The second seal portion 48 is a portion extending in a strip shape in the length direction of the drug package 40, and is a lateral seal portion extending in the lateral direction when the drug package 40 is viewed from the front. The width direction of the drug package 40 is also the width direction of the folded paper 31, and the length direction of the drug package 40 is also the length direction of the folded paper 31.
The extending direction of the first seal portion 47 and the extending direction of the second seal portion 48 are directions intersecting each other (directions orthogonal to each other in the present embodiment). The extending direction of the second sealing portion 48 is the same as the transporting direction of the packing paper 31 at the time of manufacturing the drug packaging 40. Further, when the drug packaging band 41 is formed, the direction is the same as the arrangement direction of the drug packages 40 belonging to the drug packaging band 41.

The first seal portions 47 are formed at positions separated from each other in the length direction of the drug package 40, and more specifically, they are formed on both ends of the drug package 40 in the length direction. That is, one drug package 40 is from the portion where one first seal portion 47 is formed to the portion where the other first seal portion 47 is formed. Therefore, when one medicine package 40 is made from the strip-shaped packing paper 31, the first seal portion 47 becomes a partition portion that separates one medicine package 40 from another part.

The second seal portion 48 extends between the two first seal portions 47. Specifically, a folded portion of the folded paper 31 that is folded in half is located at one end in the width direction of the drug packaging 40, and the second sealing portion 48 is an end portion that is paired with the one end portion. Is located in. That is, the second seal portion 48 is formed at a position separated from the folded portion in the width direction of the folded portion 40, and closes the portion opposite to the folded portion.

That is, the accommodation space 45 is a space in which three sides are closed by two first seal portions 47 and one second seal portion 48, and the other one is closed by a folded portion.

When the drug packaging device 30 forms the drug packaging 40, first, as shown in FIG. 6A, the first sealing operation (vertical sealing operation) is executed. This first seal operation is an operation executed with the two first heating bodies 61 as the heating posture, and is an operation of forming the first seal portion 47. By this first sealing operation, the first first sealing portion 47a (FIG. 6 (b)) is located on the downstream side of the packing paper 31 in the feeding direction (which is also the traveling direction and is also simply referred to as the feeding direction). ) Etc.).
That is, the packing paper 31 is positioned between the heating surfaces 61a of the two first heating bodies 61 and between the heating surfaces 62a of the two second heating bodies 62. Then, the two heating surfaces 61a of the first heating body 61 and the two heating surfaces 62a of the second heating body 62 are in contact with the packing paper 31. As a result, the portions of the packing paper 31 that are in contact with the heating surfaces 61a and 62a are heated, and the first sealing portion 47a is formed. Then, the portion of the packing paper 31 that is downstream in the feeding direction is closed by the first sealing portion 47a.

Subsequently, as shown in FIG. 6 (b), the second seal operation (horizontal seal operation) is executed. The second seal operation is an operation executed with the two first heating bodies 61 in a non-heating posture, and is an operation of forming a part or all of the second seal portion 48. By executing this second seal operation once or a plurality of times, the second seal portion 48 is formed in the portion on the upstream side in the delivery direction from the already formed first seal portion 47a.
The second sealing operation is an operation of simultaneously executing an operation of sending out the packing paper 31 and an operation of fusing (adhering) the packing paper 31. That is, the portion of the packing paper 31 located between the two first heating bodies 61 is in a state of being located between the two non-heating surfaces 61b. As a result, the two first heating bodies 61 and their heating surfaces 61a are in a state where the packing paper 31 does not come into contact with each other. On the other hand, the portion of the packing paper 31 located between the two second heating bodies 62 is in contact with these two heating surfaces 62a. As a result, the portion sandwiched between the two heating surfaces 62a is fused. Further, by rotating the two second heating bodies 62 in opposite directions, the contact positions between the two heating surfaces 62a and the packing paper 31 change as the packing paper 31 is sent out. Then, the portion that has passed through the two second heating bodies 62 and the portion located between the two second heating bodies 62 are sealed portions.
Then, by forming the first first seal portion 47a and the second seal portion 48, a half-bag-shaped sachet (bag-shaped portion) having an open portion on the upstream side portion in the delivery direction is formed. It is formed.

At this time, the drug introduction operation is executed before and after the second seal operation. The drug introduction operation is an operation of supplying the drug on the packing paper 31, and the supplied drug is a drug charged into the drug inlet 23 by the above-mentioned scraping operation and scraping operation, and is being manufactured. It is a drug contained in the drug package 40 of. That is, the drug introduction operation is executed during the production of the drug package 40, more specifically, during the production of the outer portion (bag portion) of the drug package 40, and the drug is applied to the outer portion (bag portion) being produced. It is an operation to supply. The drug introduction operation executed in the packaging operation is an operation of supplying the drug for one package onto the packaging paper 31 in one or a plurality of times.
That is, in the drug introduction operation, one or a plurality of introduction operations are executed, and in the introduction operation, a predetermined amount of the drug is charged into the drug input port 23, and the charged drug is placed on the packing paper 31. It is an operation to supply.

That is, the drug that has been charged into the drug charging port 23 and has passed through the inside of the hopper member 33 is supplied to a portion that is upstream from the first first seal portion 47a in the delivery direction. The drug introduction operation may be executed in parallel with the second seal operation, may be executed before the start of the second seal operation, or may be executed after the second seal operation is executed (after completion). May be good.

Then, when the second seal operation and the drug introduction operation are completed, the first seal operation is executed again, and the second first seal portion 47b (see FIG. 2 and the like) is formed. As a result, one drug package 40 is formed. When forming a plurality of drug packages 40 (drug packaging band 41), the drug package 40 at a position connected to the produced drug package 40 is formed by the same procedure. That is, by repeating the above operation and producing the drug packages 40 one by one, a specified number of drug packages 40 are finally produced, and the drug packaging band 41 is produced. Then, the produced drug package 40 (drug packaging band 41) is dispensed to the outside of the housing from the dispensing port provided in the housing of the drug dispensing device 1.

Here, when the drug packaging band 41 is manufactured, the tip portion of the portion corresponding to the head portion (header portion or the first drug package 40) and the rear end of the portion corresponding to the last drug package 40 are produced. The portion is cut by the cutting device 35 (see FIG. 2). That is, the drug packaging band 41 is produced by cutting the tip portion, forming a plurality of drug packages 40, and then cutting the rear end portion.
On the other hand, when one medicine package 40 is manufactured, the front end portion and the rear end portion (the front end portion and the rear end portion in the delivery direction (transportation direction)) of the portion corresponding to one medicine package 40 in the packing paper 31 Cut each. That is, the drug package 40 is manufactured by cutting the front end portion of the portion corresponding to one drug package 40 to prepare the drug package 40 and then cutting the rear end portion.
When the drug packaging band 41 is manufactured, perforations may be formed at the boundary between the two drug packages 40 belonging to the drug packaging band 41 to be manufactured.

Here, the drug dispensing device 1 of the present embodiment can execute a recovery operation of collecting the drug dropped (discharged) from the drug container 10 when the prescription is changed after the start of the above-mentioned packaging operation. It is a thing. The recovery operation, which is a characteristic operation of the present embodiment, will be described in detail below.

The collection operation is an operation started by the user operating the display device 5 after the start of the packaging operation. For example, the collection operation may be started on condition that the "collection" button is displayed on the display device 5 and an operation such as pressing the area where the "collection" button is displayed is performed. In addition, when the "Cancel packaging" button is displayed and an operation such as pressing the area where this button is displayed is performed, the message "Do you want to execute the collection operation?" And the "Yes" button are displayed. You may display the "No" button. In this case, the collection operation is started on condition that an operation such as pressing the "Yes" button is performed.
That is, the collection operation may be an operation that is selectively executed based on the user's operation when the packaging operation is stopped by the user's operation or the like. Further, the collection operation is automatically executed on condition that the drug dispensing device 1 receives information (signal) indicating that the prescription has been changed from the external device in parallel with or in place of this. It may be an operation.

Further, after the above-mentioned "collection" button or "yes" button is pressed, the place designation screen for designating the collection place may be displayed. The place designation screen is, for example, a screen for displaying a part (setting area) in which the setting of "Yes / No" of the collection operation can be input and an "execution button" for each of the two (plural) distribution dishes 20. May be. That is, the collection operation is executed on condition that the drug is "collected" in one or more distribution plates 20 selected from the two (plural) distribution plates 20 and the "execution button" is pressed. It may be configured to be.
That is, the collection operation may be an operation of designating a collection place and collecting the drug from the designated collection place.

The collection operation of the present embodiment is an operation of collecting the drug at each collection location. That is, when the drug is collected from each of the two distribution dishes 20, the operation of collecting the drug (powder) from one of the distribution dishes 20 is executed, and then the operation of collecting the drug from the other distribution dish 20 is executed. ..

In the recovery operation, as shown in FIG. 7, a recovery drug package 50 (hereinafter, also simply referred to as a recovery drug package 50), which is a drug package different from the normal drug package 40, is produced, and the recovery drug package is prepared. 50 contains the drug to be recovered.

In the recovery drug package 50 of the present embodiment, the length L1 in the length direction described above is longer than the length L2 in the same direction of the normal drug package 40 (see FIG. 2). That is, the recovery drug package 50 is a drug package larger than the normal drug package 40, and the volume of the storage space 45 (maximum capacity of the drug) is larger than the volume of the storage space 45 of the normal drug package 40. ..
The normal drug package 40 is a drug package 40 produced when the drug to be collected in the recovery drug package 50 is provided to the patient in a separate packaging operation.

That is, since the second seal portion 48 is formed by the above-mentioned second seal operation, by continuing to convey the packing paper 31 while keeping the two first heating bodies 61 in the non-heating posture, the above-mentioned length L1 Can be any length sufficiently longer than the normal length L2. Further, by continuing to execute the second seal operation intermittently (continuing to repeatedly execute the second seal operation having a short transport distance), the above-mentioned length L1 can be set to an arbitrary length sufficiently long. In other words, it is possible to make it a very long length that cannot be manufactured by a conventional drug packaging device, such as three times the length (3 x L2) or four times the length (4 x L2) of the normal drug packaging 40. be.

Specifically, when the drug package 50 for recovery is produced, the first seal operation is executed in the same manner as in the case of producing the drug package 40 by the above-mentioned packaging operation, and the first first seal portion. Form 47a. Subsequently, the second seal operation and the drug introduction operation are executed.
The drug introduction operation executed in the collection operation is an operation of supplying the drug to be collected (powder on the distribution dish 20) onto the packing paper 31. That is, similarly to the above, it is an operation of supplying a predetermined amount of powder charged into the medicine charging port 23 onto the packing paper 31 by the scraping operation and the scraping operation.

Here, the drug (powder) has different particle size, particle size, hygroscopicity, etc. for each type. Therefore, the ease of movement (easiness of flow) on the packing paper 31 is different. That is, the behavior of the medicine introduced on the packing paper 31 at the time of packaging differs depending on the type of the medicine, and there are those that easily flow on the packing paper 31 and those that do not easily flow on the packing paper 31.

Therefore, in the recovery operation of the present embodiment, when the second sealing operation and the drug introduction operation are executed, the second is based on the type of the drug to be recovered (movability of the drug contained in the recovery drug package 50). The number of times the sealing operation is executed (the number of times the packing paper 31 is sent out) and the number of times the medicine is introduced in the medicine introducing operation (the number of times of the feeding operation) are determined.

Specifically, each drug is assigned a set value according to the ease of movement. The set value is a value divided into a plurality of stages (five stages in the example) such as the set value 1 to the set value 5. This set value is a value assigned after experimenting with the ease of movement of the drug in advance. This set value is associated with information for identifying the drug (drug ID, drug name, etc.) and is stored in the storage unit of the drug dispensing device 1. That is, when the collection operation is executed, the operation of specifying the set value of the drug to be collected is executed based on the prescription data and the information stored in the storage unit. That is, an operation for specifying the ease of flow of the drug is executed. The operation for specifying this set value is an operation that is executed before the second seal operation is executed, and may be executed before the start of the recovery operation or may be executed after the start of the recovery operation. It should be noted that this set value may be a higher value for a drug that is easier to flow (drug with higher mobility), and conversely, a value may be lower for a drug that is easier to flow (drug with higher mobility). In the present embodiment, the value is set higher as the drug is easier to flow.

Then, when the collected drug is easy to flow (the set value is high), the second seal portion 48 is formed by one feeding operation. In the drug introduction operation in this case, the drug to be recovered may be introduced (supplied) by one introduction operation, or the drug may be introduced by a plurality of introduction operations. For example, if the amount of powder to be collected is an amount that can be charged into the drug inlet 23 at one time, one introduction operation may be executed, and if not, a plurality of introduction operations may be executed. The number of executions of the introduction operation in this case may be determined based on the amount of the drug that can be charged into the drug inlet 23 at one time.

On the other hand, when the drug to be collected is difficult to flow (the set value is low), the second seal portion 48 is formed by the feeding operation a plurality of times (for example, 5 times). At this time, the number of executions of the introduction operation in the drug introduction operation is the same as the number of executions of the delivery operation.
That is, a part of the second seal portion 48 (hereinafter, also referred to as a first portion) is formed with the first feeding operation. Then, after the first sending operation is completed (or between the start and the completion), the first introduction operation is executed. Then, after the first feeding operation and the first introduction operation are completed, another part (hereinafter, also referred to as a second part) of the second seal portion 48 is formed while executing the second feeding operation. Perform the action. This second part is a part that follows the first part that has already been formed. Then, after the second sending operation is completed (or between the start and the completion), the second introduction operation is executed. Subsequently, after the second feeding operation and the second introduction operation are completed, the other part (hereinafter, also referred to as the third part) of the second seal portion 48 is executed while executing the third feeding operation. Perform the forming action. This third part is a part that follows the second part that has already been formed. Then, after the third sending operation is completed (or between the start and the completion), the third introduction operation is executed. Similarly, this operation is repeated to form the second seal portion 48, and the supply of all the chemicals to be collected is completed.
In the introduction operation to be executed a plurality of times, the introduction amount (supply amount) of the drug for each introduction may be the same or different. All the drugs to be finally recovered may be introduced.

More specifically, in the present embodiment, when collecting the drug belonging to the category with the highest mobility (the drug having the highest set value), the number of executions of the delivery operation (second seal operation) is determined. It is set to once. The more the drug belongs to the category with lower mobility (the drug with the lower set value), the more times the delivery operation is executed. That is, the lower the mobility (difficult to flow on the packing paper 31), the larger the number of times the delivery operation is executed.

Further, in the present embodiment, the length L1 (the length of the second seal portion 48) of the recovery drug package 50 is determined according to the type of the drug to be recovered.
Specifically, the specific gravity of each type of drug is different, and even if the weight is the same, the volume is different. Therefore, even when recovering a drug having the same weight (for example, 300 g), the appropriate volume of the storage space 45 for accommodating the recovered drug differs depending on the type of the drug. Therefore, in the present embodiment, the length of the second seal portion 48 formed by the second seal operation is determined based on (depending on) the type of the drug to be recovered. As a result, the recovery drug package 50 having an appropriate size can be produced for each type of drug to be collected, so that the recovery drug package 50 to be produced does not become larger than necessary, and the packing paper 31 (recovery drug package) can be produced. Waste of 50 raw materials) can be reduced.

As described above, in the recovery operation of the present embodiment, the length of the second seal portion 48 to be formed and the number of executions of the delivery operation when forming the second seal portion 48 are determined based on the type of the drug to be recovered. is doing. Then, the number of executions of the introduction operation in the drug introduction operation is determined based on the number of executions of the delivery operation (type of the drug to be collected) and the amount of the drug that can be supplied at one time.

Then, when the second seal operation and the drug introduction operation are completed, the first seal operation is executed again in the same manner as the above-mentioned packaging operation. As a result, the recovery drug package 50 containing the recovery drug is formed. Then, the collected drug package 50 for collection is discharged to the outside from the dispensing port provided in the housing of the drug dispensing device 1, whereby the collecting operation is completed.

In this way, when the powder is collected in one drug package (recovery drug package 50) larger than the normal drug package 40, the drug packaging band 41 (see FIG. 2) is produced as usual, and the powder is powdered from the drug package band 41. The time required for collection can be shortened as compared with the case of collecting. That is, since the number of the first seal portions 47 can be reduced as compared with the case where the drug packaging band 41 is manufactured as usual, the time required for manufacturing can be shortened. Further, by reducing the number of executions of the introduction operation, the time required for production can be shortened. Further, when the drug packaging band 41 is produced as usual, it takes time because it is necessary to break the drug packaging 40 belonging to the drug packaging band 41 one by one. Since it is sufficient to break one of the recovery drug packages 50, it can be done in a short time.
In addition, by reducing the number of the first seal portions 47 as described above, the overall length can be shortened as compared with the case of producing the drug packaging band 41 (recovery than the total length of the drug packaging band 41). The length L1 of the drug package 50 can be shortened). Therefore, the number of packing papers 31 required for collection can be reduced.

In the above-described embodiment, the first heating body 61, which is a member for manufacturing the first sealing portion 47, and the second heating body 62, which is a member for manufacturing the second sealing portion 48, form a packing paper. The sealing device 34b arranged at the same position in the transport direction of 31 has been described.
However, the drug packaging device adopted in the present invention is not limited to this. For example, as shown in FIG. 8, a sealing device 134 may be provided in which the first heating body 161 and the second heating body 162 are provided at positions separated from each other in the transport direction of the packing paper 31. In this sealing device 134, the second heating body 162 is located downstream of the first heating body 161 in the transport direction of the packing paper 31, and the second sealing portion 48 is downstream of the first sealing portion 47. Formed on the side. Also in this sealing device 134, the first heating body 161 and the second heating body 162 rotate by receiving power supply from different power supply sources, and each of them can rotate individually.
That is, the operation of forming a part or all of the second seal portion 48 can be performed independently of the operation of forming the first seal portion 47, and the length of the second seal portion 48 can be arbitrarily changed. Any sealing device will do.

In the above-described embodiment, an example is shown in which the recovery operation is an operation executed based on the prescription data. That is, in the above example, the type (drug type) of the drug to be collected that was scheduled to be packaged is acquired from the prescription data, and the ease of movement of the drug is determined based on the acquired information and the information stored in the storage unit in advance. Identified. Then, based on the acquired information and the specified information, the operation of sending out the packing paper 31 and the operation of introducing the drug were executed. In addition, as another example, an example is shown in which the amount of the drug to be collected (the amount of the drug to be packaged) is acquired from the prescription data, and the number of times the drug introduction operation is executed is determined based on the acquired information. .. However, the recovery operation of the present invention is not limited to this. For example, the recovery operation may be an operation (hereinafter, also referred to as an unreferenced recovery operation) that is executed without referring to the prescription data.

In the unreferenced collection operation, the operation of collecting the drug at the collection location (on the distribution plate 20) and supplying it to the drug packaging device 30 (recovery drug supply operation) and the operation of producing the drug package 50 for recovery (recovery drug). Perform the packaging operation). At this time, the same operation is performed regardless of the type and amount of the drug to be collected.

The recovery drug supply operation in the unreferenced recovery operation may be, for example, an operation of executing a scraping operation for the entire area (one round) of the groove portion of the distribution plate 20. That is, the scraping operation is executed once or a plurality of times so that the rotation angle of the distribution plate 20 at that time becomes 360 degrees in total. As described above, the collection place of the drug may be the entire portion (groove portion) in the member (distribution dish 20) serving as the collection place where the drug to be collected may exist.
In addition, in the recovery drug supply operation, an operation of performing a scraping operation on a part of the groove portion of the distribution plate 20 may be performed. In this case, the total rotation angle of the distribution pan 20 when performing one or a plurality of scraping operations is an angle smaller than 360 degrees. That is, the drug collection location may be a part of a portion (groove portion) in which the drug to be collected may exist in the member (distribution dish 20) that serves as the collection location.

Here, a case where powder is collected from a part of the groove portion of the distribution dish 20 will be described. For example, it is assumed that the normal packaging operation is executed, the packaging operation is stopped with a part of the powder already supplied to the distribution dish 20 being charged into the drug charging port 23, and the collection operation is started. In this case, the powder that was not charged into the drug charging port 23 due to the preceding packaging operation remains in the distribution dish 20. That is, the powder remains in a part of the groove portion of the distribution plate 20, and the powder in the other portion is scraped out from the distribution plate 20.

In this case, the scraping operation is executed for the area where the drug to be collected exists in the member (distribution dish 20) serving as the collection place. That is, in the collection operation, an operation of specifying a portion (collection place) where the powder remains in the groove portion of the distribution dish 20 is executed. That is, of the groove portion of the distribution dish 20, the portion (region) in which the scraping operation was performed by the prior packaging operation is specified, and the other portion excluding this portion is the portion where the powder remains. do. Then, a scraping operation is performed on the portion where the drug to be recovered exists.
Even when the powder remains only in a part of the groove portion of the distribution dish 20 as described above, the scraping operation may be performed on the entire groove portion of the distribution dish 20. Further, even when the collection operation is executed while referring to the prescription data as in the above-described embodiment, the entire groove portion of the distribution plate 20 may be used as the collection place for the powder, and a part of the groove portion of the distribution plate 20. May be used as a collection place for powdered medicine.

Then, when the scraping operation is executed once in the collecting operation, the scraping operation is executed after the scraping operation is executed.
On the other hand, when the scraping operation is executed a plurality of times, for example, the scraping operation may be executed every time the scraping operation is completed, and the scraping operation may be executed every time the scraping operation is executed. You may perform the action. For example, when the scraping operation is finally executed 12 times, the operation of executing the scraping operation twice and then executing the scraping operation once may be repeated. The scraping operation performed after a plurality of scraping operations performed once or continuously is not limited to one time, and may be continuously executed a plurality of times.

The recovery drug supply operation in the unreferenced recovery operation may be an operation of executing a predetermined number of scraping operations. At this time, the total rotation angle of the distribution pan 20 in one or a plurality of scraping operations may be an angle of 360 or more. That is, it may be rotated more than one round. When the scraping operation is executed a plurality of times, the rotation angle of the distribution pan 20 for each scraping operation may be the same or different for each scraping operation.
For example, when the rotation angle in each of the plurality of scraping operations is the same, the scraping operation executed at the specified rotation angle X1 (for example, 12 degrees) is executed n times (for example, 33 times). In this case, n may be an integer of 360 / X1 or more.
On the other hand, when the rotation angle in each of the plurality of scraping motions is an indefinite rotation angle, the rotation angle in each scraping motion is the minimum rotation angle X2 (for example, 5 degrees) in which the scraping motion can be executed. It becomes the above angle. For example, the first rotation angle is 5 degrees, the second rotation angle is 10 degrees, and so on. In this case, when the number of executions of the scraping operation is n times, n may be an integer of 360 / X2 or more.
Also in this case, similarly to the above, the scraping operation is executed after a plurality of scraping operations performed once or continuously, but this scraping operation is not limited to one time, but is continuously performed a plurality of times. You may do it.

Further, the recovery drug supply operation in the unreferenced recovery operation may be an operation of repeating a series of operations including one or a plurality of scraping operations and scraping operations for a specified time. For example, an operation consisting of one execution of the scraping operation and one execution of the scraping operation may be repeatedly executed for 3 minutes. In the same manner as above, the scraping operation is executed after a plurality of scraping operations performed once or continuously, but this scraping operation may be executed once or continuously executed a plurality of times. You may.

Further, the recovered drug supply operation in the unreferenced recovery operation may be an operation completed on condition that the recovered drug has disappeared from the collection location.
In this case, for example, the hopper member 33 is provided with a lid member (not shown) that can be opened and closed, and the hopper member 33 in the closed state is charged with the drug. Then, by shifting the lid member to the open state, the medicine in the hopper member 33 is supplied to the folded paper 31 folded in half. That is, the structure is such that the drug can be temporarily retained in the hopper member 33. Then, a sensor member capable of detecting whether or not there is a drug in the hopper member 33 is provided.

Then, an operation of repeating a series of operations including a plurality of scraping operations and scraping operations performed once or continuously is executed. This operation is executed until it is determined that the drug to be collected has disappeared from the collection site. Further, the scraping operation in this operation is not limited to once, but may be continuously performed a plurality of times in the same manner as described above.
Further, every time the scraping operation is executed once or a plurality of times in a series of operations, the charging determination operation for determining whether or not the drug has been charged to the hopper member 33 is executed. This charging determination operation is an operation of determining whether or not a drug has been charged into the hopper member 33 by detecting whether or not there is a drug in the hopper member 33.

Then, it is determined that the drug to be collected has disappeared from the collection place on the condition that it is determined that the drug has not been added by the multiple injection determination operations.
Explaining in detail with an example, it is assumed that it is determined that the drug has been added in the first injection determination operation, and similarly, it is determined that the drug has been added up to the fourth injection determination operation. Then, it is assumed that it is determined that the drug has not been added in the fifth to seventh injection determination operations. In this way, it is determined that the drug has not been added by any one of the injection determination operations (fifth in the above example), and the injection determination operation executed thereafter extends over a specified number of times (twice in the above example). When it is determined that the drug has not been continuously added, it is determined that the drug to be collected has disappeared from the collection place.

In this case, the recovered drug packaging operation executed by the drug packaging device 30 is an operation of transporting the packing paper 31 (a part of the second seal portion 48 is formed, provided that it is determined that the drug has been charged. Operation) may be executed. For example, it is assumed that the first first seal portion 47a is formed and it is determined that the drug is charged in the first injection determination operation. In this case, a drug is supplied onto the packing paper 31 from inside the hopper member 33, and before and after that, the packing paper 31 is conveyed to produce a portion that becomes a part of the second sealing portion 48. That is, the second seal operation is executed to form a part or all of the second seal portion 48.

After that, the above operation is repeated every time it is determined that the drug has been added. Then, on condition that it is determined that the drug to be collected has disappeared from the collection place, the second first seal portion 47b is formed, and the production of the drug package 50 for recovery is completed.
In the above example, after forming the second seal portion 48 in four steps, when it is determined in the fifth loading determination operation that the drug has not been charged, the packing paper 31 is conveyed and sealed (second). Do not perform the sealing operation). Similarly, the transfer and sealing of the packing paper 31 are not executed even after the sixth and seventh loading discrimination operations. Then, after the seventh input determination operation, the second first seal portion 47b is formed.

By the way, the drug (powder) to be recovered includes a drug that easily rises upward when it is put into the hopper member 33 and a drug that does not easily fly upward. Therefore, when the collection operation is performed based on the prescription data, the waiting time before the start of transportation of the packing paper 31 may be a time determined based on the type of the drug to be collected (easiness to fly up). .. Here, the "waiting time before the start of transport of the packing paper 31" means that the medicine is charged into the hopper member 33 and then the medicine is supplied from the hopper member 33 onto the packing paper 31. This is the time until the transfer of the wrapping paper 31 (second sealing operation) is started.
In this case, the set value may be set based on the ease of soaring, as in the case of assigning the set value based on the ease of movement in the above-described embodiment. Further, the waiting time may be specified for each type of drug.
When the collection operation is an operation that does not refer to the prescription data, the "waiting time before the start of transportation of the packing paper 31" may be a specified time. This specified time may be the time required to reliably recover the drug that is most likely to fly up, which has been found in advance by experiments or the like.

By the way, in the above-mentioned recovery operation (recovery drug supply operation), the scraping operation is executed after a plurality of scraping operations performed once or continuously. Here, in one or a plurality of scraping operations executed before the scraping operation, if the total rotation angle of the rotating distribution dishes 20 is large, the amount of the drug to be charged into the hopper member 33 at one time is large. Can be considered. That is, when the powdered drug spread over a wide area is scraped onto the distribution dish 20, it is conceivable that the amount of the drug charged into the hopper member 33 at one time increases. On the contrary, when the total rotation angle of the distribution pan 20 is small, it is conceivable that the amount of the medicine to be charged into the hopper member 33 at one time is small.

Therefore, when it is predicted that the amount of the chemicals to be charged into the hopper member 33 at one time will be large, the transport speed of the packing paper 31 may be faster than when the amount of the chemicals is predicted to be small. That is, the transport speed of the packing paper 31 may be changed according to the operation of supplying the powder to be collected to the drug packaging device 30.
For example, the packing paper 31 is targeted for one or more scraping operations to be executed before the execution of one scraping operation, and is rotated according to the total rotation angle of the distribution pan 20 rotated by the targeted scraping operation. To change the transport speed of. Specifically, when the total value of the rotation angles is a specified angle (for example, 90 degrees) or more, the transport speed of the packing paper 31 in the second sealing operation is increased as compared with the case where the total value is smaller than the specified angle. Similarly, the above-mentioned "waiting time before the start of transport of the packing paper 31" is also shortened when the amount of the drug to be charged into the hopper member 33 at one time is predicted to be large, and long when the amount of the drug is predicted to be small. You may.

Here, the above-mentioned packaging operation may be an operation executed based on the packaging setting information stored in the above-mentioned storage means. At this time, the above-mentioned collection operation may be an operation executed based on the collection setting information stored in the above-mentioned storage means. That is, the packaging operation and the collecting operation may be operations in which the information referred to (used) at the time of execution is different. Then, the packaging operation and the collecting operation may be executed as follows. Overlapping description will be omitted for the same parts as those in the above-described embodiment.

The packaging setting information includes information for determining the number of drug packages 40 produced by the packaging operation. It also includes information for determining the rotation angle of the distribution plate 20 in the above-mentioned scraping operation. Further, it contains information for determining the length of the second seal portion 48 of the drug package 40 produced by the packaging operation. In addition, it includes information for determining the transport speed of the packing paper 31 (the feeding speed in the feeding operation described above) when the second sealing portion 48 is formed in the packing operation.
In the present embodiment, the "information for determining the number of drug packages 40 to be produced by the packaging operation" is information for controlling the operation of calculating the number of drug packages 40 to be produced based on the prescription data. .. Further, the "information for determining the rotation angle of the distribution plate 20 in the scraping operation" is for controlling the operation for calculating the rotation angle of the distribution plate 20 based on the calculated number of drug packages 40. Information. The "information for determining the length of the second seal portion 48 of the drug packaging 40 produced by the packaging operation" is information indicating a specified length (predetermined length), and is "in the packaging operation". "Information for determining the transport speed of the packing paper 31 when forming the second seal portion 48" is information indicating a specified speed (predetermined speed).

That is, when it is decided to execute the packaging operation, the packaging setting information is referred to before and after that. As a result, it is determined that the operation of calculating the number of the drug packages 40 to be produced based on the prescription data is executed, and the operation is executed. For example, if it is specified by referring to the prescription data that the prescribed drug is taken 3 times a day in the morning, noon, and night, and for 7 days, it is based on the acquired information. Therefore, it is decided to prepare 3 × 7 = 21 drug packages (21 packages). Further, when the number of the drug packages 40 to be produced is determined, the rotation angle of the distribution plate 20 in the scraping operation is calculated based on the determination. This rotation angle is an angle of 360 (degrees) / n (n is an integer of 1 or more) when the number of the drug packages 40 to be produced is n. For example, when 21 drug packages 40 are produced as described above, 360 (degrees) / 21≈17.1 (degrees).

Further, by referring to the packaging setting information, the length of the second sealing portion 48 of the drug packaging 40 produced by the packaging operation and the transport speed of the packaging paper 31 when forming the second sealing portion 48 can be obtained. Will be done. Then, in the packaging operation, the second seal portion 48 is conveyed while transporting the packaging paper 31 at a speed (specified speed) based on the acquired information so that the length is based on the acquired information (specified length). To form. For example, when the length of the acquired second seal portion 48 is the specified length X mm and the transport speed of the acquired packaging paper 31 is Y mm / s, the packaging paper 31 is loaded at a speed of Y mm / s. While feeding out, a second seal portion 48 of X mm is formed, and so on.

The recovery setting information is information for determining the length of the second seal portion 48 of the recovery drug package 50 produced by the recovery operation and the distance between the two first seal portions 47a and 47b (hereinafter, also referred to as drug package length determination information). Includes). It also includes information for determining the transport speed of the packing paper 31 when forming the second seal portion 48 in the recovery operation. Further, when the recovery drug package 50 is manufactured by the recovery operation, it includes information for determining whether or not the drug introduction operation and the delivery operation (production of the second seal portion 48) are simultaneously executed. The collection setting information may include prescription data or information acquired from the prescription data.

The "medicine package length determination information" is information for controlling a discrimination operation for determining how to determine the length of the second seal portion 48 (the distance between the two first seal portions 47a and 47b). May be good. The "length of the second seal portion 48" is the total length of the second seal portion 48 formed in one recovery drug package 50. That is, the length of the second seal portion 48 may be a length that is changed based on the type of the drug (powder) to be recovered. Further, it may have a specified length (predetermined length). In addition to these, the length may change depending on the circumstances. Further, the length may be determined based on the amount of drug to be recovered. Further, the length may be determined based on the type and amount of the drug (powder) to be recovered.

That is, when it is decided to execute the collection operation, the collection setting information is referred to before and after that. Then, based on the "drug package length determination information", it is determined how to determine the length of the second seal portion 48 of the recovery drug package 50. In addition, information for determining the transport speed of the packing paper 31 when forming the second seal portion 48 of the recovery drug package 50 is acquired. In the present embodiment, the information is information indicating a specified speed (predetermined speed).
In addition, it is determined whether or not the drug introduction and delivery operations are executed at the same time. Then, in each of the cases described later, unless otherwise specified, when it is determined that the drug introduction and delivery operations are to be executed at the same time, the drug introduction operation is executed during the production of the second seal portion 48. On the other hand, when it is determined that the drug introduction and delivery operations are not executed at the same time, the drug introduction operation is executed before or after the production of the second seal portion 48.

When it is determined that the length of the second seal portion 48 is changed based on the type of the drug (powder) to be recovered, the length of the second seal portion 48 is determined according to the drug to be recovered. Then, the recovery drug package 50 is manufactured while feeding the packing paper 31 at the acquired specified speed so that the second seal portion 48 has a determined length.

When it is determined that the length of the second seal portion 48 is the specified length, the collection setting information is referred to and information indicating the specified length (predetermined length) is acquired. Then, the recovery drug package 50 is manufactured while feeding the packing paper 31 at the acquired specified speed so that the second seal portion 48 has the acquired specified length.
Here, when the length of the second seal portion 48 is set to the specified length, even if the second seal portion 48 is formed by one second seal operation (the operation of feeding out and the operation of fusing the packing paper 31). It may be formed by a plurality of second seal operations. The number of executions of the second seal operation is also determined by referring to the collection setting information.
For example, when the second seal portion 48 is formed by two second seal operations, it may be formed as follows. That is, a part of the second seal portion 48 is formed by the first second seal operation, and the delivery operation is stopped. Then, the drug introduction operation is executed to introduce all the drugs to be recovered, and the remaining portion of the second seal portion 48 is formed by the second second seal operation. The length of a part of the second seal portion 48 formed by the first second seal operation is n2X (n2 is a number larger than 0 and smaller than 1) when the specified length is X mm, for example. , 0.9 × X mm. That is, when the second seal portion 48 is formed by the second seal operation a plurality of times, the length of each portion produced by each second seal operation may be the same or may be different. .. Further, when the lengths are different, the length of the portion to be produced earlier may be longer than the length of the portion to be produced later.
In addition, even when it is determined that the above-mentioned "length of the second seal portion 48 is changed based on the type of the drug to be recovered", similarly, the second seal portion 48 is used once or more than once. It may be formed by the second sealing operation of the times.

Further, as a result of the above determination, when the length of the second seal portion 48 is a length that changes in the course, the length of the second seal portion 48 is set in order to introduce the transport speed of the sending operation and the drug to be recovered. Determined by the time required. In this case, the drug introduction and delivery operations are performed in parallel.
Here, the "time required to introduce the drug to be recovered" is the execution time of the drug introduction operation, which is the time from the start to the end of the scraping device 22 for executing the drug introduction operation.
That is, the delivery operation is executed at the determined transfer speed to manufacture the second seal portion 48, and the drug introduction operation is executed while manufacturing the second seal portion 48. Then, when the drug introduction operation is completed, the production of the second seal portion 48 is completed, and the second first seal portion 47b is produced. In addition, in the operation of determining whether or not the "drug introduction operation is completed", a sensor is provided in the drug collection path such as the hopper member 33, and the drug detection is started from the start of the drug introduction operation, and the drug cannot be detected. On the condition that this is the case, it may be determined that the "drug introduction operation is completed". That is, it may be determined that the "drug introduction operation is completed" on the condition that the drug cannot be recovered after the drug introduction operation (drug recovery operation) is started. The drug recovery route is any of the members through which the drug passes during drug recovery.

In addition, the operation of determining whether or not the "drug introduction operation has been completed" is whether or not the operation for collecting the entire part of the member to be collected where the drug to be collected exists has been completed. It may be determined by. For example, in the case of collecting the drug from the distribution dish 20, the "drug introduction operation" is performed on condition that the scraping operation and the scraping operation for the entire groove portion (all 360 degrees) of the distribution dish 20 are completed. It is determined that "has been completed".

Further, when the length of the second seal portion 48 is set to a length that changes as a matter of course, a plurality of collection drug packages 50 are provided on condition that the length of the second seal portion 48 to be manufactured is equal to or more than a certain length. It may be produced. That is, the length of the second seal portion 48 being manufactured is detected by a sensor or the like, and the second first seal portion 47b is formed on condition that the length of the second seal portion 48 becomes a certain value or more. Then, the first recovery drug package 50 is prepared. Subsequently, the first first seal portion 47a is formed by the second recovery drug package 50, and while the remaining drug is recovered, the second (two) has the same length as above. The second seal portion 48 of the recovery drug package 50 (after the eyes) is formed, and so on. That is, when producing a plurality of collection drug packages 50, the first and second collection drug packages 50 (for example, in the case of producing three, the first and the second) other than the one package to be produced last. (2) The seal portion 48 has a predetermined maximum length. Then, one packet to be produced at the end has a predetermined maximum length or less.

Further, when the length of the second seal portion 48 is determined to be the length determined based on the amount of the drug to be recovered, the operation of calculating the amount of the drug to be recovered based on the prescription data is executed.
In this case, the amount of the drug to be recovered is the value obtained by subtracting the amount of the drug already packaged (packed) from the amount of the drug (powder) that was planned to be packaged based on the prescription data. For example, if it is determined that 21 drug packages 40 are produced by the packaging operation and only 2 of them have already been packaged, the amount of drug to be collected is "amount of drug per package". It becomes × (21-2). Then, a predetermined length is assigned in advance according to the amount of the drug to be collected, and the length of the second seal portion 48 is determined from the calculated amount of the drug to be collected and the length assigned to the amount of the drug. do. In this case, the length of the second seal portion 48 may be determined based on the volume of the drug instead of the amount (weight) of the drug. The volume of the drug is the weight of the drug divided by the density of the drug.

The information for determining the transport speed of the packing paper 31 when forming the second seal portion 48 in the packing operation or the collecting operation described above is information indicating the specified speed described above, and the type of the drug. The speed may be set for each (depending on the type of drug).

The drug dispensing device 1 of the above-described embodiment is a powder packaging machine, but the present invention is not limited to this. For example, the drug packaging manufacturing apparatus of the present invention may be a tablet packaging machine. That is, it may be an apparatus capable of enclosing one or a plurality of tablets (drugs), which are one packet (one dose), in one drug package and paying out. In this tablet packing machine, tablets may be automatically supplied from a drug cassette (drug container) stored by the tablet to perform a packing operation, or a user manually supplies tablets to a tablet packing machine to perform a packing operation. You may do it.

When the drug packaging manufacturing device is a tablet packaging machine, a drug cassette (prescription-compatible cassette) into which a drug corresponding to one prescription (prescription data) is introduced may be designated as a collection place. That is, it is not a drug cassette that stores a large amount of the same type of drug in advance, but a drug cassette that introduces a drug corresponding to the prescription each time a prescription-based packaging operation is executed. In this drug cassette, the size of the discharge port may be changed each time the drug is introduced, based on the prescription data. That is, it may be a drug cassette in which the type of drug that can be discharged (supplied) is changed each time the prescription data is input (every time the drug is introduced).

Further, the drug packaging manufacturing device may be a drug packaging manufacturing device capable of separating tablets and powders. For example, it may be a drug packaging manufacturing device in which a cassette shelf holding a plurality of tablet cassettes each containing a tablet and a powder packaging machine are combined.
That is, the drug dispensing device 1 may be provided with a drug packaging device that packages a drug in a predetermined dosage form (drug type) and produces a drug package containing the drug.

Then, in the drug packaging manufacturing apparatus capable of the above-mentioned packaging operation for the tablets, the tablets may be collected by the above-mentioned collection operation. That is, the recovery operation of accommodating the tablets to be recovered in the recovery drug package 50 may be executed. Further, in the drug packaging manufacturing apparatus capable of separating tablets and powders, it may be possible to input the setting of "Yes / No" of the collection operation for the tablets on the above-mentioned place designation screen. That is, on the location designation screen (setting area), at least one of the collection operation for powder and the collection operation for tablets may be set to "do / do not". In addition to designating the collection location of powdered medicine, it may be possible to specify the collection location of tablets.

The recovery operation of the above-described embodiment has described an example in which a drug package 50 (recovery drug package 50) larger than the normal drug package 40 is produced and the drug is recovered, but the present invention is not limited to this. .. The drug package for recovery produced by the recovery operation may be smaller than the normal drug package 40 (L1 may be shorter than L2). For example, when the amount of the drug to be recovered is very small, it is conceivable to form such a drug package for recovery. In this case, the amount of packing paper 31 required for collection can be reduced.

Further, in the above-described embodiment, an example in which all the drugs to be recovered are included in one recovery drug package 50 has been described, but the present invention is not limited to this. In the recovery operation, a plurality of (multiple packages) of drug packages for recovery may be prepared, and the drugs to be collected may be separately included in the plurality of drug packages for recovery. In this case, it is preferable to produce a recovery drug packaging band in which a plurality of recovery drug packages are connected. Further, each of the plurality of recovery drug packages may be different in size from the normal drug package 40, or may be the same size. The number of recovery drug packages to be produced may be less than the number of drug packages to be produced when the drug to be collected is provided to the patient. However, it is preferable that the drug package for recovery has a size different from that of the normal drug package 40 (larger or smaller than the normal drug package 40).
For example, on the condition that the recovered amount of the drug is obtained and the recovered amount of the drug is equal to or more than a predetermined predetermined amount, the drug to be recovered is separately contained in the recovery drug package 50 of a plurality of packages (for example, 2 packets). It may be configured to make it. In this case, if the amount of the drug to be recovered is less than a predetermined amount, the drug to be recovered is contained in one recovery drug package 50. The "specified amount" may be an amount specified for each drug type, or may be a specified amount regardless of the drug type.

In addition, when producing a drug package for recovery, the number of drug packages for collection to be produced may be specified by input on the above-mentioned location designation screen. That is, it may be possible to input the setting of "Yes / No" of the collection operation, and when it is set to "Yes", it is possible to input the number of drug packages for collection to be produced. At this time, it may not be possible to input a number larger than the specified number (for example, the number of drug packages to be produced when the drug to be collected is provided to the patient).

The above-mentioned recovery drug package 50 may be provided with information that can identify the recovery drug package 50 and its accessory parts as the recovery drug package. The "attached portion" referred to here may be a hooder portion provided on the opposite tail side in addition to the header portion provided on the head side described above. The hooder portion is also formed by the blank. That is, a header portion may be provided on the front side of the first seal portion 47a on the head side of the drug package 50 for recovery, and a hooder portion may be provided on the tail side of the first seal portion 47b on the tail side. It may be provided.
Then, as "information that can be identified as the drug packaging for collection", for example, characters such as "It is a powder to be collected" may be displayed by the printing means 36. The term "characters, etc." as used herein means characters, numbers, symbols, figures, patterns or other codes. In addition, information related to the recovery operation such as information on the time when the drug was recovered, information on the type of the recovered drug, information on the amount of the recovered drug, and the like may be attached. These may be displayed as characters or the like, or may be displayed as a code (one-dimensional code or two-dimensional code). The information regarding the time when the drug is recovered is, for example, the time when the recovery operation is executed (the time at the start of execution and / or the time at the end of execution). The information regarding the type of the recovered drug is, for example, the drug name. Information about the amount of recovered drug is, for example, the total weight (grams) of the recovered drug.

The recovery operation of the above-described embodiment is an operation of collecting the drug at each collection location, but the present invention is not limited to this. For example, it may be an operation of collecting the drug from all recoverable places (for example, both of the two distribution dishes 20). That is, in the collection operation, the drug may be collected at each recoverable place, or the drug may be collected from a plurality of collection places. In other words, it may be an operation of collecting the drug from one or more collection points.

The collection operation of the above-described embodiment has described the case where the delivery operation is executed a plurality of times and the number of executions of the delivery operation is the same as the number of executions of the introduction operation in the drug introduction operation, but the present invention is limited to this. It's not a thing.
For example, a part of the second seal portion 48 is formed along with the first feeding operation, and after the first feeding operation is completed (or until it is completed), two introduction operations are executed. The second seal portion 48 may be formed by repeating the above steps, and all the chemicals to be collected may be supplied. That is, the number of executions of the introduction operation may be larger than the number of executions of the delivery operation. In other words, the number of executions of the introduction operation and the delivery operation may be different.
That is, when the second seal portion 48 is formed in a plurality of times and the drug introduction operation is executed, the number of executions of the introduction operation corresponding to one delivery operation is a plurality of times even if it is once. You may.

Further, when the sending operation is executed a plurality of times, the sending operation may be performed at least once without the introduction operation. That is, in at least one delivery operation, the number of executions of the introduction operation corresponding to the delivery operation may be 0.
For example, a part of the second seal portion 48 is formed along with the first feeding operation, and after the first feeding operation is completed (or until it is completed), one or a plurality of introduction operations are executed. .. Subsequently, the second sending operation is executed, and then the third sending operation is executed. Further, another part of the second seal portion 48 is formed with the second feeding operation, and further another part of the second seal portion 48 is formed with the third feeding operation. At this time, the introduction operation is not executed from the start of the second sending operation to the start of the third sending operation. Then, after the third delivery operation is completed (or until it is completed), one or a plurality of introduction operations are executed, and so on.

The drug dispensing device 1 of the above-described embodiment is a powder packaging machine having a distribution dish 20 and a scraping device 22, but the drug packaging manufacturing device of the present invention is not limited to this. For example, as shown in the figure, the drug packaging manufacturing device of the present invention may be a so-called V-shaped drug dispensing device 201 (drug packaging manufacturing device).

The drug dispensing device 201 has a V box portion 202 (drug introduction section), a split container 203, and a drug packaging device 30. Then, the powdered drug supplied to the V-box 202 is divided into packages by the dividing container 203 and supplied to the drug packaging device 30, so that the drug packaging 40 can be manufactured.

The V-square portion 202 has a first side wall portion 202a and a second side wall portion 202b, and an introduction groove portion 202c is formed by these. The introduction groove portion 202c is a groove portion having a V-shaped cross-sectional shape and narrowing in width toward the lower side. At least one of the first side wall portion 202a and the second side wall portion 202b is rotatably formed in the V-square portion 202, and the bottom portion can be opened and closed by rotation. Further, the V-box portion 202 is provided with a partition plate portion (not shown) inside, and the partition plate portion can be moved along the length direction of the V-box portion 202.

The split container 203 is provided at a position on the lower side of the V box portion 202 and on the upper side of the drug packaging device 30. The divided container 203 has a plurality of small container portions 210 arranged side by side. Specifically, it has 21 small container portions 210 composed of a first small container portion 210a to a 21 small container portion 210t. An opening / closing lid is provided on the bottom portion of each small container portion 210, and the bottom portion can be opened / closed individually. Further, in the split container 203, the entire split container 203 or each of the small container portions 210 can be slidably moved in the parallel direction of the small container portions 210. From this, it is possible to arrange any one or more small container portions 210 on the upper part of the hopper member 33.

For example, when the first small container portion 210a and the second small container portion 210b move to the left from the state shown in FIG. 8, the first small container portion 210a is separated from the upper part of the hopper member 33, and the second small container portion 210a is separated. The portion 210b is arranged on the upper part of the hopper member 33. Similarly, from that state, the first small container portion 210a and the second small container portion 210b move to the left, and the third small container portion 210c moves to the left, so that the third small container portion 210c becomes a hopper member. It is in a state of being arranged on the upper part of 33, and so on.

Subsequently, the packaging operation executed by the drug dispensing device 201 will be described. First, in the case of producing the maximum number (21 packages) of drug packages 40 that can be produced, the partition plate portion is positioned at the end portion of the V box portion 202 in the length direction. Then, 21 packets of powder are introduced into the V-box 202, and the introduced powder is evenly distributed over the entire length direction of the V-box 202. At this time, it is assumed that a plurality of small container portions 210 are arranged below the V-box portion 202, and one of the small container portions 210 is located on the lower side of each portion forming the bottom portion of the V-box portion 202. .. That is, the first small container portion 210a is located on the lower side of the portion of the V box portion 202 on the left end side of FIG. 8, and the second small container portion 210b is located on the lower side of the portion adjacent to the portion. Is.
The step of evenly smoothing the powder may be manually performed by a person, or may be automatically performed by providing a leveling plate member or the like in the drug dispensing device 201.

Then, by opening the bottom portion of the V-square portion 202, the powder introduced into the V-square portion 202 falls and is introduced into each of the 21 small container portions 210. At this time, the amount of powdered medicine introduced into each small container portion 210 is equal or substantially equal.

Then, each small container portion 210 is sequentially moved to the upper part of the hopper member 33, and the bottom portion of the small container portion 210 is opened, so that the powder is supplied to the drug packaging device 30 one by one. Then, in the same manner as in the above embodiment, the powdered medicine supplied by the medicine packaging device 30 is packaged.
Next, a case where the number of drug packages 40 to be produced is smaller than the maximum number that can be produced will be described. In this case, the partition plate portion is moved to a position corresponding to the number (number of packages) to be manufactured, which is an intermediate portion in the length direction of the V-box portion 202. For example, in the case of producing two packages, the partition plate portion is located above the position serving as the boundary between the second small container portion 210b and the third small container portion 210c in FIG.
Then, ascenders for the number of packages to be prepared are introduced into a part of the range of the V-square portion 202. Here, the range (introduction range) for introducing the powder is from one end (left end in FIG. 8) defined in the lengthwise end of the V-square portion 202 to the partition plate portion. Further, at this time, a plurality of small container portions 210 are arranged on the lower side of the introduction range. For example, in the case of producing two packages, the first small container portion 210a and the second small container portion 210b are located on the lower side of the introduction range. Then, in the same manner as described above, after the powder is evenly distributed over the entire introduction range, the powder is introduced into the small container section 210 from the introduction range, and the powder is supplied from the small container section 210 to the drug packaging device 30.

Next, the powder collection operation executed by the drug dispensing device 201 of the present embodiment will be described. In the above-described embodiment, the drug discharged from the drug container 10 is used as the drug to be collected, and the drug supplied to the distribution dish 20 is used as the drug to be collected. On the other hand, in the present embodiment, the powder supplied to the V-box 202 and the powder supplied to the divided container 203 are the agents to be collected. That is, the V-square portion 202 and the divided container 203 are the collection locations. The recovery operation of the present embodiment is also an operation of collecting the powder supplied for the (discontinued) packaging operation that was scheduled to be performed.

When the V-square portion 202 serves as a collection place, an operation of introducing powder from the V-square portion 202 into the small container portion 210 is executed in the same manner as the above-mentioned packaging operation. This introduces the powder to be collected into one or more small container portions 210. When introducing powder to be collected in a plurality of small container portions 210, it is not always necessary to evenly distribute the powder. That is, in the recovery operation, the powder may be introduced evenly or substantially evenly into the plurality of small container portions 210, and the amount of the powder to be introduced into each of the small container portions 210 may be non-uniform. It should be noted that substantially equality allows an error of several percent, and "non-uniformity" means a state in which a variation equal to or greater than the error occurs. In other words, "non-uniformity" here is meant to exclude being even or substantially equal.

Subsequently, the operation of supplying the powder to be collected from the split container 203 to the drug packaging device 30 is executed. In this operation, one or a plurality of target small container portions 210 execute an operation of opening the bottom portion at the upper portion of the hopper member 33.
Here, when the number of drug packages 40 scheduled to be produced by the discontinued packaging operation is the maximum number (21), all the small container portions 210 are targeted. On the other hand, when the number of drug packages 40 to be produced is less than the maximum number, the small container portion 210 (first small container portion 210a, second small container portion 210b in the above example) corresponding to the introduction range is targeted. Will be.
The recovery operation may be an operation targeting all the small container portions 210 regardless of the number of drug packages 40 to be produced. That is, even when the number of drug packages 40 is less than the maximum number, all the small container portions 210 may execute the operation of opening the bottom portion at the upper portion of the hopper member 33.

When there are a plurality of target small container portions 210, the operation of opening the bottom portion of the small container portion 210 at the upper portion of the hopper member 33 may be sequentially executed one by one, or may be executed collectively. good. For example, when executing one by one in sequence, one small container portion 210 moves to the upper part of the hopper member 33 and executes an operation of opening the bottom portion. Then, one small container portion 210 executes an operation of moving from the upper part of the hopper member 33 to another place, and the other small container portion 210 moves to the upper part of the hopper member 33 in parallel or back and forth. Performs the action of opening the bottom part. Hereinafter, this operation is repeated, and all the target small container portions 210 execute an operation of opening the bottom portion at the upper portion of the hopper member 33.

Further, when a plurality of small container portions 210 are collectively executed, an operation of moving a predetermined number of small container portions 210 such as two or three to the upper part of the hopper member 33 is executed. Then, each of the plurality of small container portions 210 located at the upper part of the hopper member 33 executes an operation of opening the bottom portion. Hereinafter, this operation is repeated, and all the target small container portions 210 execute an operation of opening the bottom portion at the upper portion of the hopper member 33.
By the above operation, the powder to be collected is supplied to the drug packaging device 30.

By the way, when the powder is evenly supplied to the plurality of small container portions 210 and the powder is sequentially supplied one by one from each of the small container portions 210 to the drug packaging device 30, the powder is gradually dispensed in the same manner as in the normal packaging operation. Is supplied. On the other hand, when the powder is non-uniformly supplied to the plurality of small container portions 210, or when the powder is supplied to the hopper member 33 from the plurality of small container portions 210, the amount of the powder to be supplied to the hopper member 33 at one time is divided. It is possible that it will be more than the wrapping motion.

Therefore, as in the above-described embodiment, the transport speed of the packing paper 31 in the drug packaging device 30 is changed depending on whether the powder is supplied little by little or when a large amount of powder is expected to be supplied at one time. May be good.
In the drug packaging device 30, the drug package 50 for recovery is produced in the same manner as described above. Further, when the divided container 203 serves as a collection place, the powder to be collected is supplied to the drug packaging device 30 in the same manner as described above, and the drug packaging device 30 prepares the drug packaging 50 for collection.

1; drug dispensing device (drug packaging manufacturing device), 40; drug packaging, 50; recovery drug packaging (drug packaging), 45; storage space, 47; first seal part (seal part, delivery forming part), 48 Second seal part (seal part, partition part), 201; drug dispensing device (drug packaging manufacturing device)

Claims (6)

A drug packaging manufacturing device that manufactures drug packaging containing drugs.
It is possible to enclose the drug in the drug package of the specified size and to dispense the drug package of the specified size by the specified number.
A recovery operation for recovering the drug that was planned to be used in the packaging operation is possible, and in the recovery operation, the recovered drug is encapsulated in the drug package having a size different from the specified size, and / Or, a drug package manufacturing device to be included in the drug package in a number smaller than the specified number. The drug packaging manufacturing apparatus according to claim 1, wherein in the recovery operation, the drug to be collected is contained in one drug package having a size larger than the specified size. The drug package has a storage space in which the drug is stored and a seal portion adjacent to the storage space, and the storage space is closed by the seal portion.
The drug packaging manufacturing apparatus according to claim 1 or 2, wherein in the recovery operation, the length of the seal portion of the drug package containing the drug to be recovered is changed according to the type of the drug to be recovered. The drug package has a storage space in which the drug is stored and a seal portion adjacent to the storage space, and the storage space is closed by the seal portion.
The sealing portion includes a delivery forming portion which is a portion formed by sealing while feeding out the packing paper.
The drug package production according to any one of claims 1 to 3, wherein in the recovery operation, the number of times of feeding the packing paper is changed according to the type of the drug to be collected in the operation of forming the delivery forming portion. Device. The packaging operation is an operation executed based on the packaging setting information.
The drug packaging manufacturing apparatus according to any one of claims 1 to 4, wherein the collection operation is an operation executed based on the collection setting information. The drug package has a storage space in which the drug is stored and a seal portion adjacent to the storage space, and the storage space is closed by the seal portion.
The sealing portion includes a delivery-time forming portion, which is a portion formed by sealing while feeding out the packing paper, and a partition portion, and the partition portion is in a direction intersecting the extending direction of the delivery-time forming portion. It is an extending part,
The packaging setting information is information for determining the number of the drug packages produced by the packaging operation, and for determining the length of the delivery forming portion of the drug packaging produced by the packaging operation. Contains one or more pieces of information selected from information, information for determining the delivery speed of the packing paper when making the drug packaging in the packing operation.
The collection setting information is information for determining whether to simultaneously introduce the drug and send out the packing paper when the drug package is manufactured in the recovery operation, and the drug package produced in the recovery operation. A claim comprising one or more information selected from information for determining the spacing of the dividers, information for determining the delivery speed of the packing paper when making the drug packaging in the recovery operation. Item 5. The drug packaging manufacturing apparatus according to Item 5.

Images